Stock screener

KPTI

Conviction 69HealthcareScan · Mon, Jul 20, 2026
KPTI$7.45-21.66%
ResistanceSupportVol 14Insider sell
63 bars
6
Vol MA14 1.06M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Karyopharm Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.karyopharm.com
Price7.45
Change-21.66%
Gap-1.05%
Rel volume18.43×
Avg volume1.02M
Avg $ vol8.87M
SMA 209.66
SMA 509.14
SMA 2007.60
Price vs 50-18.49%
Price vs 200-1.99%
MA stackmixed
50/200 cross
Supertrenddown · 10.52
RSI (14)32
MACD hist-0.23
MACD crossbear · 3d
Stoch %K / %D22 / 17
ADX (14)33
+DI / −DI16 / 36
RSI divergence
MACD divergence
ATR %+10.88%
ADR %8.20%
52w high10.67
52w low3.77
From 52w high-30.18%
Above 52w low+97.61%
New 52w highNo
SqueezeFired
Bollinger width26.96%
%B-0.35
Donchian pos21.61%
Donchian high10.86
Donchian low6.51
AVWAP (52w high)7.71
vs AVWAP high-3.31%
AVWAP (52w low)7.47
vs AVWAP low-0.24%
OBV trendDown
Chaikin MF (20)-0.01
Today vs 20d18.43×
Avg vol (14d)1.06M
Avg vol (20d)1.02M
Avg $ vol (20d)8.87M
Market cap168.84M
RS 3m (vs SPY)+3.88%
RS 6m (vs SPY)+24.60%
RS line new highNo
Trend template5/8
Technical rank37.8
1 week-25.87%
1 month-20.74%
3 months-13.47%
6 months+11.86%
1 year+83.05%
YTD+3.62%
P/E-0.86
P/B-0.64
P/S1.16
P/FCF-2.24
EPS-17.93
Div yield
ROE73.80%
ROA-149.17%
Debt/Eq-0.64
Current1.08
EV/EBITDA-2.76
Gross margin
Net margin-134.21%
Rev growth0.57%
EPS growth-156.52%
Price target12.00
Target upside61.07%
Analyst ratingBuy
Institutional80.86%
Ent. value247.28M
Revenue35.07M
Net income-22.39M
Gross profit
Free cash flow-75.37M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out
Employees228
ListedWed, Nov 6, 2013
Free float17.98M
Float %98.0%
Short interest6.58M
Days to cover9.1d
Short volume67.6%
Squeeze score98 / 100
Next earnings
EPS forecast
Last EPS vs est−$1.24 vs −$1.45
Last surprise+14.5% beat
Setup gradeB
Conviction69 / 100
Pattern quality
Tech rank37.8 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance10.67
Support8.45
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KPTI

All disclosures →
No recent disclosed trades by Congress in KPTI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KPTI · 6 buys · 4 sells

InsiderSideShares
PAKIANATHAN DEEPIKA
Director · Common Stock · 2026-05-21
Grant15.51K
Su Zhen
Director · Common Stock · 2026-05-21
Grant15.51K
Schor Chen
Director · Common Stock · 2026-05-21
Grant15.51K
Greene Barry E
Director · Common Stock · 2026-05-21
Grant15.51K
Oliger Christy J.
Director · Common Stock · 2026-05-21
Grant15.51K
BOHLIN GAREN G
Director · Common Stock · 2026-05-21
Grant15.51K
Poulton Stuart
EVP, Chief Development Officer · Common Stock · 2026-05-14
Sell403
Cheng Sohanya Roshan
EVP & Chief Commercial Officer · Common Stock · 2026-05-14
Sell324
Paulson Richard A.
President and CEO · Common Stock · 2026-05-14
Sell2.2K
Abate Kristin
Chief Accounting Officer · Common Stock · 2026-05-14
Sell53

SEC filings

EDGAR filings in KPTI · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.